[Defects of neutrophil function in chronic gastroduodenitis in children]

Insights

Chronic gastroduodenitis in children involves neutrophils. Fungal infections like Candida albicans alongside Helicobacter pylori significantly impair neutrophil function, indicating a need for immunocorrection in treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Chronic gastroduodenitis (CGD) is a prevalent gastrointestinal disease in children.
  • Helicobacter pylori (HP) is a primary cause, but fungal flora, particularly Candida albicans, is increasingly implicated.
  • Understanding neutrophil function is crucial for managing pediatric CGD.

Purpose of the Study:

  • To evaluate the functional activity of neutrophils in children with CGD.
  • To differentiate neutrophil responses to HP alone versus HP with Candida albicans co-infection.
  • To identify specific immune phenotype alterations in pediatric CGD.

Main Methods:

  • Flow cytofluorimetry was used to study neutrophil phagocytic activity and immune phenotype.
  • 110 children aged 7-17 with CGD were analyzed.
  • Participants had CGD associated with HP, or HP and Candida albicans co-infection.

Main Results:

  • Distinct differences in neutrophil phagocytic activity were observed between bacterial (HP) and fungal (Candida albicans) co-infections.
  • Neutrophil immune phenotype transformation correlated with depressed phagocytic and microbicidal functions.
  • Co-infection with HP and Candida albicans showed more pronounced functional impairment.
  • Candida albicans mannan protein antigen altered neutrophil surface receptors, affecting adhesion and cytolysis.

Conclusions:

  • Pediatric CGD involves significant neutrophil phenotype transformation, varying with bacterial and fungal co-infections.
  • The findings highlight the impact of Candida albicans on neutrophil immunity in pediatric CGD.
  • Therapeutic strategies for CGD co-infected with Candida albicans should incorporate immunocorrection.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...